f**********g
发帖数: 2252 | 1 Vical announces issuance of US patent for cytomegalovirus vaccine
34 minutes ago - DTM via Comtex
DatamonitorVical Incorporated, a biopharmaceutical company, has announced
the issuance of US patent covering DNA vaccines for cytomegalovirus, or CMV,
containing specific gene sequences and formulated with Vical's Vaxfectin
adjuvant.
Past development by others of protein-based prophylactic CMV vaccines has
focused on antibody-mediated immune responses against the CMV glycoprotein B
(gB) antigen, whi... 阅读全帖 |
|
f**********g
发帖数: 2252 | 2 Vical announces issuance of US patent for cytomegalovirus vaccine
34 minutes ago - DTM via Comtex
DatamonitorVical Incorporated, a biopharmaceutical company, has announced
the issuance of US patent covering DNA vaccines for cytomegalovirus, or CMV,
containing specific gene sequences and formulated with Vical's Vaxfectin
adjuvant.
Past development by others of protein-based prophylactic CMV vaccines has
focused on antibody-mediated immune responses against the CMV glycoprotein B
(gB) antigen, whi... 阅读全帖 |
|
f**********g
发帖数: 2252 | 3 来自主题: _pennystock版 - vicl SLOW COW.
Publication Highlights Allovectin-7(R) Phase 2 Safety and Efficacy Results
in Melanoma
6 hours 15 minutes ago - PMZ
GlobeNewswireVical Incorporated (Nasdaq:VICL) today announced a new
publication summarizing results from the company's completed trials of
Allovectin-7(R) including systemic responses and an excellent safety profile
in patients with metastatic melanoma. An article published in the January
issue of Immunotherapy1 noted that the U.S. incidence of melanoma is
increasing rapi... 阅读全帖 |
|
f**********g
发帖数: 2252 | 4 来自主题: _pennystock版 - vicl SLOW COW.
Publication Highlights Allovectin-7(R) Phase 2 Safety and Efficacy Results
in Melanoma
6 hours 15 minutes ago - PMZ
GlobeNewswireVical Incorporated (Nasdaq:VICL) today announced a new
publication summarizing results from the company's completed trials of
Allovectin-7(R) including systemic responses and an excellent safety profile
in patients with metastatic melanoma. An article published in the January
issue of Immunotherapy1 noted that the U.S. incidence of melanoma is
increasing rapi... 阅读全帖 |
|
f**********g
发帖数: 2252 | 5 Vical Presentations on TransVax(TM) and DNA Vaccines at ASGCT Conference
3 hours 35 minutes ago - PMZ via Comtex
GlobeNewswireVical Incorporated (Nasdaq:VICL) announced today that the
company will present a summary of Phase 2 data for the company's TransVax(TM
) therapeutic cytomegalovirus (CMV) vaccine, and a review of clinical-stage
DNA vaccine development programs, both at the 14th Annual Meeting of the
American Society of Gene & Cell Therapy, (Seattle -- May 18-21).
Alain P. Rolland, Pharm.D... 阅读全帖 |
|
f**********g
发帖数: 2252 | 6 VICL are strong.
Vical to Present at Bank of America/Merrill Lynch Health Care Conference
4 hours 9 minutes ago - PMZ via Comtex
GlobeNewswireVical Incorporated (Nasdaq:VICL) today announced that Vijay B.
Samant, President and Chief Executive Officer, will provide an overview of
the company's technologies, development programs, and outlook on Wednesday,
May 11, at 3:00 p.m. PDT (6:00 p.m. EDT) at the Bank of America/Merrill
Lynch Health Care Conference (Las Vegas, May 10 -- 12).
A webcast of Mr.... 阅读全帖 |
|
f**********g
发帖数: 2252 | 7 Kevin's father, could u say sth about VICL? Very pig.
Vical to manufacture plasmid DNA vaccines against HIV
Monday 10/11/2010 9:42 AM ET - Datamonitor
Related Companies
Symbol Last %Chg
VICL 2.23 -1.33%
As of 10:29 AM ET 10/11/10
Vical, a biopharmaceutical company, has agreed to manufacture plasmid DNA
vaccines against HIV under a $2.4 million contract with the IPPOX Foundation
, a collaborating institution for the Poxvirus Vaccine Regimen Design led by
the Centre Hospitalier Universitaire Vaudo... 阅读全帖 |
|
f**********g
发帖数: 2252 | 8 来自主题: _pennystock版 - VICL Vical Extends Collaboration With U.S. Government for Emerging Disease
Vaccines
3 hours 36 minutes ago - PMZ via Comtex
GlobeNewswireVical Incorporated (Nasdaq:VICL) announced today that the
company has extended its relationship with the U.S. Naval Medical Research
Center (NMRC) to develop its platform technology for the rapid development
and production of vaccines against emerging infectious diseases.
Vical received U.S. government funding from Defense Threat Reduction Agency
and NMRC in 2010 to... 阅读全帖 |
|
f**********g
发帖数: 2252 | 9 来自主题: _pennystock版 - VICL Vical Extends Collaboration With U.S. Government for Emerging Disease
Vaccines
3 hours 36 minutes ago - PMZ via Comtex
GlobeNewswireVical Incorporated (Nasdaq:VICL) announced today that the
company has extended its relationship with the U.S. Naval Medical Research
Center (NMRC) to develop its platform technology for the rapid development
and production of vaccines against emerging infectious diseases.
Vical received U.S. government funding from Defense Threat Reduction Agency
and NMRC in 2010 to... 阅读全帖 |
|
f**********g
发帖数: 2252 | 10 Vical to manufacture plasmid DNA vaccines against HIV
Monday 10/11/2010 9:42 AM ET - Datamonitor
Related Companies
Symbol Last %Chg
VICL 2.20 -0.45%
As of 10:17 AM ET 10/12/10
Vical, a biopharmaceutical company, has agreed to manufacture plasmid DNA
vaccines against HIV under a $2.4 million contract with the IPPOX Foundation
, a collaborating institution for the Poxvirus Vaccine Regimen Design led by
the Centre Hospitalier Universitaire Vaudois under the auspices of the
collaboration for AIDS va... 阅读全帖 |
|
f**********g
发帖数: 2252 | 11 Sell on news. Did not drop much. may just a correction.
Vical Expects To Begin Phase 3 Trial In 2nd Half >VICL
6 hours 57 minutes ago - DJNF
Vical: European Agency Recommends Efficacy Endpoints For Phase 3
6 hours 58 minutes ago - DJNF
Vical Evaluating Plans For Phase 3 Trial With FDA >VICL
6 hours 59 minutes ago - DJNF |
|
f**********g
发帖数: 2252 | 12 Sell on news. Did not drop much. may just a correction.
Vical Expects To Begin Phase 3 Trial In 2nd Half >VICL
6 hours 57 minutes ago - DJNF
Vical: European Agency Recommends Efficacy Endpoints For Phase 3
6 hours 58 minutes ago - DJNF
Vical Evaluating Plans For Phase 3 Trial With FDA >VICL
6 hours 59 minutes ago - DJNF |
|
|
f**********g
发帖数: 2252 | 14 CEO has 526,000 shares!
7.Vical Inc. (VICL): Vical is a $142 million biopharma engaged in the
development of treatments using its DNA delivery technology. They have a
number of drugs at different stages of development and testing. The stock
traded near $4 in September, but poor results from a clinical trial and a
secondary offering priced at $2.25 cut the legs out of the share price. CEO
Vijay Samant picked up 500 shares on February 4 for $1,000. You have to
wonder why it was even worth the trou... 阅读全帖 |
|
f**********g
发帖数: 2252 | 15 CEO has 526,000 shares!
7.Vical Inc. (VICL): Vical is a $142 million biopharma engaged in the
development of treatments using its DNA delivery technology. They have a
number of drugs at different stages of development and testing. The stock
traded near $4 in September, but poor results from a clinical trial and a
secondary offering priced at $2.25 cut the legs out of the share price. CEO
Vijay Samant picked up 500 shares on February 4 for $1,000. You have to
wonder why it was even worth the trou... 阅读全帖 |
|
f**********g
发帖数: 2252 | 16 Seven Stocks With CEO Buying in the Past Week
by: Steven Kiel February 08, 2011 |
about: ACLS / BKMU / MOFG / NL / NPTN / ORI / VICL
http://seekingalpha.com/article/251438-seven-stocks-with-ceo-bu
When looking at insider purchases, CEO and CFO buying is a better indicator
than board purchases. Since management is dealing with day to day matters,
they have a better idea of what may be a positive catalyst for the stock.
These are great indicators because insiders only make purchases on the open... 阅读全帖 |
|
f**********g
发帖数: 2252 | 17 Seven Stocks With CEO Buying in the Past Week
by: Steven Kiel February 08, 2011 |
about: ACLS / BKMU / MOFG / NL / NPTN / ORI / VICL
http://seekingalpha.com/article/251438-seven-stocks-with-ceo-bu
When looking at insider purchases, CEO and CFO buying is a better indicator
than board purchases. Since management is dealing with day to day matters,
they have a better idea of what may be a positive catalyst for the stock.
These are great indicators because insiders only make purchases on the open... 阅读全帖 |
|
v**********m
发帖数: 5516 | 18 Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript summaries
1 potential new partnerships
We are projecting a net cash burn for 2011 of $22 million to $27 million,
including projected cash from new or expanded partnerships for which we do
not currently have contracts.
2 VICL will initiate our Phase 3 trial for TransVax CMV vaccine for HCT
patients in the second half of 2011.
3 Allovectin-7 三期数据(银杏曾提到过这个）
VICL expects to lock the clinical data trial database for Allovectin-7 in
the se... 阅读全帖 |
|
f**********g
发帖数: 2252 | 19 It will up today!
报导日期：2011/02/14 08:06
Vical的Allovectin-7第三阶段实验数据获得SMB正面评价
(VICL: 报价, 研究资料) 1.74 : Vical宣布，Allovectin-7第三阶段实验的安全监督
委员会(SMB)完成该实验第五次安全分析，建议继续进行实验，Allovectin-7治疗恶性
黑色素瘤。 |
|
v**********m
发帖数: 5516 | 20 Vical CEO Discusses Q4 2010 Results - Earnings Call Transcript summaries
1 potential new partnerships
We are projecting a net cash burn for 2011 of $22 million to $27 million,
including projected cash from new or expanded partnerships for which we do
not currently have contracts.
2 VICL will initiate our Phase 3 trial for TransVax CMV vaccine for HCT
patients in the second half of 2011.
3 Allovectin-7 三期数据(银杏曾提到过这个）
VICL expects to lock the clinical data trial database for Allovectin-7 in
the se... 阅读全帖 |
|
f**********g
发帖数: 2252 | 21 It will up today!
报导日期：2011/02/14 08:06
Vical的Allovectin-7第三阶段实验数据获得SMB正面评价
(VICL: 报价, 研究资料) 1.74 : Vical宣布，Allovectin-7第三阶段实验的安全监督
委员会(SMB)完成该实验第五次安全分析，建议继续进行实验，Allovectin-7治疗恶性
黑色素瘤。 |
|
w****r
发帖数: 245 | 22 大侠，分类都分好了，求神签
# Basic Materials, Agricultural Chemicals
AGU Agrium Inc.
AVD American Vanguard Corp.
CAGC China Agritech Inc.
CF CF Industries Holdings, Inc.
CGA China Green Agriculture, Inc.
CMP Compass Minerals International
COIN Converted Organics Inc.
IPI Intrepid Potash, Inc.
MON Monsanto Co.
MOS Mosaic Co.
NOEC New Oriental Energy & Chemical
POT Potas... 阅读全帖 |
|
|
f*******g
发帖数: 35 | 24 麻烦问一下 大家谁在用pVR1012 这个vector？我在网上查到 这个vector 是Vical,
Inc. 公司的， 但没有相关的信息阿！ 这个vector的reverse and forward
sequencing primer sequence是什么呢？
谢谢！ |
|
w***y
发帖数: 2537 | 25 【 以下文字转载自 Stock 讨论区 】
发信人: ll111 (Stealth), 信区: Stock
标 题: Events and ER for week August 2-6
发信站: BBS 未名空间站 (Sun Aug 1 22:47:17 2010, 美东)
Monday, Aug. 2
10 a.m.: ISM Manufacturing index on business activity in July, released by
the Institute for Supply Management.
10:15 a.m. Federal Reserve Chairman Ben Bernanke speaking on "challenges for
the economy and state governments."
4 p.m. Treasury Secretary Timothy Geithner speaking on the next steps for
financial reform.
Tuesday, Aug. 3
8:30 a.m.: P... 阅读全帖 |
|
|
|
t*******o
发帖数: 1464 | 28 09年时候几个flu股，后来出成药的有谁啊？
BioCryst Pharmaceuticals Inc. (BCRX)
Novavax, Inc. (NVAX)
Sinovac Biotech Ltd. (SVA)
Vical Inc. (VICL)
Inovio Biomedical Corporation (INO)
CEL-SCI Corp. (CVM) |
|
t*******o
发帖数: 1464 | 29 09年时候几个flu股，后来出成药的有谁啊？
BioCryst Pharmaceuticals Inc. (BCRX)
Novavax, Inc. (NVAX)
Sinovac Biotech Ltd. (SVA)
Vical Inc. (VICL)
Inovio Biomedical Corporation (INO)
CEL-SCI Corp. (CVM) |
|
|
y*****l
发帖数: 5997 | 31 公司及药品：
维考公司正在研发的药物很多，和政府合作，开发预治艾滋病毒的疫苗。公司现金充足
，够烧到2012年，近期不用担心稀释圈钱，没有FDA，比较安全。主要炒点是二季度的
melanoma三期。
Allovectin - 7，第三阶段临床试验，治疗转移性黑色素瘤的产品。这个很牛X，非2上
映后，国内谈黑色素色变，到医院祛痣的人，比往年翻了好几倍。
TransVax，一二期临床试验，防止移植后病毒复发和疾病。
还有一些在早期研究中：
H5N1流感疫苗，一期临床试验。
H1N1甲流疫苗，临床前试验
CyMVectin，防止孕前和孕期感染，临床前试验
单纯疱疹2型病毒，研究中，没影儿。
庄家:
这个庄家是玩长期的，看起来很不错，图形走得很规矩，慢牛。
主力平均成本2块，花了7个月的时间吸筹，洗筹，老骥伏枥，志在千里。保守估计庄家
至少要拉到4块才能赚钱。
这个庄很好，贴着10日线走，边拉边歇，没有震仓。不管大盘，埋头拉车一步步往上爬
。走自己的路，让别人跌去吧。
双底图形:
圣诞前，VICL从第一个底部缓缓启动。银杏看到后大喊一声：“放跑了EXEL，下一个可
能会轮到VICL!”大家一听... 阅读全帖 |
|
y*****l
发帖数: 5997 | 32 Vical Started At Buy By Canaccord Genuity >VICL |
|
d******8
发帖数: 1972 | 33 http://www.thestreet.com/story/11351242/1/10-biotech-stock-pred
BOSTON (TheStreet) -- Ten biotech predictions for 2012:
1. The Amgen(AMGN_) strategy of returning cash to shareholders in form of
share buybacks, Dutch tender offers and dividends is abandoned in favor of
ramped up acquisitions i.e. Gilead Sciences(GILD_) buying Pharmasset(VRUS_).
Large-cap biotech firms start acting like Big Pharma -- choosing to buy
growth instead of seeking it from internal drug development.
2. After much wrangli... 阅读全帖 |
|
|
